ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 135 filers reported holding ARGENX SE in Q1 2019. The put-call ratio across all filers is 3.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,416 | -13.9% | 13,051 | -31.7% | 0.07% | +30.4% |
Q2 2023 | $7,450 | +20.7% | 19,116 | +15.4% | 0.06% | -22.2% |
Q1 2023 | $6,171 | -12.0% | 16,563 | -10.5% | 0.07% | -15.3% |
Q4 2022 | $7,013 | -99.8% | 18,511 | +129.4% | 0.08% | +142.9% |
Q3 2022 | $2,849,000 | -67.3% | 8,071 | -64.9% | 0.04% | -62.4% |
Q2 2022 | $8,706,000 | +27.2% | 22,979 | +5.8% | 0.09% | +86.0% |
Q1 2022 | $6,846,000 | -45.8% | 21,711 | -39.8% | 0.05% | -27.5% |
Q4 2021 | $12,624,000 | +27.4% | 36,049 | +9.8% | 0.07% | +46.8% |
Q3 2021 | $9,912,000 | +2.7% | 32,822 | +2.4% | 0.05% | +4.4% |
Q2 2021 | $9,650,000 | +16.0% | 32,053 | +6.1% | 0.04% | +2.3% |
Q1 2021 | $8,322,000 | +239.0% | 30,219 | +262.0% | 0.04% | +238.5% |
Q4 2020 | $2,455,000 | +761.4% | 8,348 | +670.1% | 0.01% | +550.0% |
Q3 2020 | $285,000 | +82.7% | 1,084 | +56.9% | 0.00% | +100.0% |
Q2 2020 | $156,000 | -15.2% | 691 | -39.8% | 0.00% | -50.0% |
Q4 2019 | $184,000 | +53.3% | 1,148 | +35.2% | 0.00% | +100.0% |
Q2 2019 | $120,000 | -10.4% | 849 | -21.2% | 0.00% | 0.0% |
Q1 2019 | $134,000 | – | 1,077 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |